SCPX — Scorpius Holdings Share News
0.000.00%
- $0.01m
- $11.13m
- $6.24m
Brief: Heat Biologics Announces Formation Of Biothreat Advisory Board
Brief: Heat Biologics Says Commencement Of Biosecurity/Biodefense Initiative To Be Initiated Via Its Blackhawk Bio Inc Subsidiary
Heat Biologics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Heat Biologics Posts Q2 Loss Per Share Of $0.26
Heat Biologics Inc expected to post a loss of 30 cents a share - Earnings Preview
Heat Biologics Inc expected to post a loss of 30 cents a share - Earnings Preview
Heat Biologics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Heat Biologics Joins Russell Microcap Index
Brief: Heat Biologics To Showcase Favorable Survival Data Of Hs-110 In Previously Treated Non-Small Cell Lung Cancer Patients At 2021 American Society Of Clinical Oncology Annual Meeting
U.S. STOCKS ON THE MOVE-Virgin Galactic, Kohl's, Ralph Lauren, Tesla
Heat Biologics: Up ahead of data presentation at cancer society meeting
Brief: Heat Biologics Announces Survival Data Of Hs-110 In Two Treatment Settings Of Lung Cancer Selected For Presentation At 2021 American Society Of Clinical Oncology Annual Meeting
Brief: Heat Biologics Announces Multiple Presentations On PTX-35
Brief: Heat Biologics Reports Q1 Loss Per Share Of $0.31
Brief: Heat Biologics Announces New Preclinical Data On Ptx-35, Demonstrating Decreased Regulatory T-Cell (Treg) Activity And Delayed Tumor Progression
Heat Biologics: Doubles after positive cancer trial of cell therapy
Brief: Heat Biologics Announces Positive Interim Survival Data From Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial
Brief: Heat Biologics Announces Publication Of Additional Preclinical Covid-19 Vaccine Results
Brief: Heat Biologics - Effective Feb 1, Engaged Crs Crossroads Strategies To Help In Government Collaborations Related To Co's Covid-19, Other Vaccine Programs